Literature DB >> 8712731

Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at risk.

A Saetersdal1, A Dørum, K Heimdal, P Helgerud, E M Sager, P Bøhler, S Tretli, S Kvinnsland, P Møller.   

Abstract

Five hundred and thirty seven women at risk for breast carcinoma were identified. Family history was detailed and each woman given genetic counselling. Diagnostic examination for breast carcinoma was performed at the major hospitals of Norway, and included physical examination by expert surgeon, mammography and/or ultrasonography, and fine needle aspiration cytology when appropriate. Altogether 8 carcinomas and 5 cases of atypical hyperplasia were found, compared with 1.6 and 0.3 expected, respectively, from population studies. The finding exceeded the expected numbers described by autosomal dominant inheritance. In addition we found one carcinoma in situ. It is concluded that the methods employed are suitable to identify and examine women at risk for breast carcinoma. It is suggested that atypical hyperplasia may be the precancerous lesion, and should be treated as such.

Entities:  

Mesh:

Year:  1996        PMID: 8712731

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.

Authors:  Laura Cortesi; Daniela Turchetti; Isabella Marchi; Antonella Fracca; Barbara Canossi; Battista Rachele; Ruscelli Silvia; Pecchi Anna Rita; Torricelli Pietro; Federico Massimo
Journal:  BMC Cancer       Date:  2006-08-17       Impact factor: 4.430

2.  The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.

Authors:  Pål Møller; Astrid Stormorken; Marit Muri Holmen; Anne Irene Hagen; Anita Vabø; Lovise Mæhle
Journal:  Breast Cancer Res Treat       Date:  2014-03-12       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.